Published in Oncogene on February 17, 2000
Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol (2006) 1.58
Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. Endocr Rev (2008) 1.38
Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia (2009) 1.32
Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells. Breast Cancer Res (2006) 1.14
Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) (2009) 1.06
Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer. Breast Cancer Res Treat (2011) 1.04
The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer. Breast Cancer Res (2008) 1.01
Favorable prognostic value of SOCS2 and IGF-I in breast cancer. BMC Cancer (2007) 1.00
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer. PPAR Res (2009) 0.96
Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo. Am J Pathol (2008) 0.96
A novel unidirectional cross-talk from the insulin-like growth factor-I receptor to leptin receptor in human breast cancer cells. Mol Cancer Res (2008) 0.90
Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer? Breast Cancer Res (2002) 0.88
Trp53 regulates Notch 4 signaling through Mdm2. J Cell Sci (2011) 0.84
Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16
An interactive graphics-based model of the lower extremity to study orthopaedic surgical procedures. IEEE Trans Biomed Eng (1990) 5.65
Metastatic prostate cancer in a transgenic mouse. Cancer Res (1996) 4.02
Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression. Cell (1979) 3.78
Application of high-tech three-dimensional imaging and computer-generated models in complex facial reconstructions with vascularized bone grafts. Plast Reconstr Surg (1993) 2.77
A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model. FASEB J (2000) 2.73
Preparation and preliminary characterization of purified ovalbumin messenger RNA from the hen oviduct. Biochemistry (1975) 2.42
Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development (1996) 2.35
Physical and chemical characterization of purified ovalbumin messenger RNA. J Biol Chem (1975) 2.28
C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev (1998) 2.27
The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol (1994) 2.22
C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol (2000) 2.11
Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol (2001) 2.05
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene (2000) 2.03
Overlapping sites for constitutive and induced DNA binding factors involved in interferon-stimulated transcription. EMBO J (1989) 1.87
Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome. Am J Pathol (2000) 1.84
Comparison of the whey acidic protein genes of the rat and mouse. Nucleic Acids Res (1984) 1.81
Complex hormonal regulation of rat casein gene expression. J Biol Chem (1982) 1.80
Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology (1996) 1.74
Use of a specific probe for ovalbumin messenger RNA to quantitate estrogen-induced gene transcripts. Biochemistry (1975) 1.69
Regulation of casein messenger RNA during the development of the rat mammary gland. Biochemistry (1975) 1.66
Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol Endocrinol (1997) 1.50
Isolation and characterization of functional mammary gland stem cells. Cell Prolif (2003) 1.49
Extra-amniotic pregnancy. A trip to the extraembryonic coelom. J Ultrasound Med (1990) 1.47
Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J Natl Cancer Inst (1997) 1.47
The rat casein multigene family. I. Fine structure of the gamma-casein gene. J Biol Chem (1983) 1.45
Acute eosinophilic pneumonia associated with shock. Crit Care Med (1999) 1.45
Rat beta casein cDNA: sequence analysis and evolutionary comparisons. Nucleic Acids Res (1982) 1.44
GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res (1996) 1.42
Nuclear factor I and mammary gland factor (STAT5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice. Mol Cell Biol (1995) 1.37
Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development. Mol Endocrinol (1994) 1.36
Comparative sequence analysis of the mRNAs coding for mouse and rat whey protein. Nucleic Acids Res (1982) 1.35
Adenovirus-Cre-mediated recombination in mammary epithelial early progenitor cells. J Cell Sci (2001) 1.34
Localization of the casein gene family to a single mouse chromosome. J Cell Biol (1982) 1.33
Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression. Mol Endocrinol (1995) 1.32
Estrogen receptor beta expression in invasive breast cancer. Hum Pathol (2001) 1.30
The rat casein multigene family. Fine structure and evolution of the beta-casein gene. J Biol Chem (1985) 1.30
Evaluation of a fiber optic glove for semi-automated goniometric measurements. J Rehabil Res Dev (1990) 1.29
Evolution of the casein multigene family: conserved sequences in the 5' flanking and exon regions. Nucleic Acids Res (1986) 1.28
Prolactin induction of casein mRNA in organ culture. A model system for studying peptide hormone regulation of gene expression. J Biol Chem (1978) 1.27
neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol Cell Biol (1997) 1.27
Measurement of mRNA concentration and mRNA half-life as a function of hormonal treatment. Methods Enzymol (1985) 1.25
A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res (2001) 1.21
Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol (2001) 1.21
Both cell substratum regulation and hormonal regulation of milk protein gene expression are exerted primarily at the posttranscriptional level. Mol Cell Biol (1988) 1.20
Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol Endocrinol (1999) 1.18
Construction and preliminary characterization of the rat casein and alpha-lactalbumin cDNA clones. J Biol Chem (1981) 1.18
Tissue-specific expression of the rat beta-casein gene in transgenic mice. Nucleic Acids Res (1988) 1.16
Progesterone-mediated inhibition of casein mRNA and polysomal casein synthesis in the rat mammary gland during pregnancy. Biochemistry (1978) 1.16
Localization and quantification of Wnt-2 gene expression in mouse mammary development. Dev Biol (1993) 1.16
Isolation and characterization of purified rat casein messenger ribonucleic acids. Biochemistry (1976) 1.13
Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor. Mol Endocrinol (2001) 1.13
Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A. J Biol Chem (1999) 1.11
Regulation of mammary gland factor/Stat5a during mammary gland development. Mol Endocrinol (1995) 1.11
Multihormonal regulation of casein gene expression at the transcriptional and posttransciptional levels in the mammary gland. Recent Prog Horm Res (1980) 1.10
Sequence of rat alpha- and gamma-casein mRNAs: evolutionary comparison of the calcium-dependent rat casein multigene family. Nucleic Acids Res (1982) 1.10
Distal regulatory elements required for rat whey acidic protein gene expression in transgenic mice. J Biol Chem (1994) 1.09
Quantitation of casein messenger ribonucleic acid sequences using a specific complementary DNA hybridization probe. Biochemistry (1976) 1.09
A transgenic mouse model for mammary carcinogenesis. Oncogene (1998) 1.08
Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice. Oncogene (1999) 1.07
Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma. Cancer Gene Ther (2011) 1.07
Differential regulation of rat beta-casein-chloramphenicol acetyltransferase fusion gene expression in transgenic mice. Mol Cell Biol (1989) 1.06
Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland. Endocrinology (2003) 1.05
P190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer. Cell Growth Differ (2000) 1.05
Tissue-specific, high level expression of the rat whey acidic protein gene in transgenic mice. Nucleic Acids Res (1990) 1.04
Detection of mouse mammary tumor virus RNA in BALB/c tumor cell lines of nonviral etiologies. J Virol (1978) 1.04
Preferential overexpression of a 172Arg-->Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development. Cell Growth Differ (1994) 1.03
Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model. Oncogene (1999) 1.03
IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J Mammary Gland Biol Neoplasia (2000) 1.03
Backscattersonde: a new instrument for atmospheric aerosol research. Appl Opt (1991) 1.02
Glucocorticoid regulation of rat whey acidic protein gene expression involves hormone-induced alterations of chromatin structure in the distal promoter region. Mol Endocrinol (1994) 1.02
Regulation of prostate cancer cell division by glucose. J Cell Physiol (1999) 1.02
Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis. Cell Growth Differ (1997) 1.01
Renal cell carcinoma with an infrarenal vena caval tumor thrombus. Urology (1999) 0.99
Steroid hormone regulation of specific messenger RNA and protein synthesis in eucaryotic cells. J Cell Physiol (1975) 0.99
Use of PRKO mice to study the role of progesterone in mammary gland development. J Mammary Gland Biol Neoplasia (1997) 0.97
The rate and kinetic order of ethanol elimination. Forensic Sci Int (1984) 0.97
Differential interactions of specific nuclear factor I isoforms with the glucocorticoid receptor and STAT5 in the cooperative regulation of WAP gene transcription. Mol Cell Biol (2001) 0.96
High-level expression of the rat whey acidic protein gene is mediated by elements in the promoter and 3' untranslated region. Mol Cell Biol (1992) 0.96
Pathogenic significance of P-fimbriated Escherichia coli in urinary tract infections. J Urol (1985) 0.96
Renal lymphoma. The diagnostic and therapeutic roles of fine-needle aspiration. Am J Clin Pathol (2001) 0.95
Multihormonal regulation of milk protein gene expression. Ann N Y Acad Sci (1986) 0.95
Concepts of peripheral nerve repair. Ann Plast Surg (1981) 0.94
Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells. Cell Growth Differ (2001) 0.94
Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function. Cell Growth Differ (1997) 0.94
A clonal derivative of mammary epithelial cell line COMMA-D retains stem cell characteristics of unique morphological and functional heterogeneity. Exp Cell Res (1988) 0.94
Differential expression of poly(A)-adjacent sequences of mammary tumor virus RNA in murine mammary cells. Proc Natl Acad Sci U S A (1978) 0.92
Restriction enzyme mapping and heteroduplex analysis of the rat milk protein cDNA clones. J Biol Chem (1981) 0.92
Gene expression in normal and neoplastic mammary tissue. Biochemistry (1980) 0.92
Inhibition of glucose uptake in lymphosarcoma P1798 by cortisol and its relationship to the biosynthesis of deoxyribonucleic acid. J Biol Chem (1970) 0.91
Mutant p53 and genomic instability in a transgenic mouse model of breast cancer. Oncogene (2000) 0.91
Monitoring in microvascular surgery. Ann Plast Surg (1991) 0.89
Malignant tumors arising in endometriosis: clinical-pathological study and flow cytometry analysis. Eur J Obstet Gynecol Reprod Biol (1996) 0.88
Mammary tumour virus and casein gene transcription during mouse mammary development. Nature (1978) 0.88
Infarction of the upper limbs associated with oligohydramnios and intrauterine compression. J Hand Surg Am (1988) 0.88